Date: October 01, 2023
Classification: Frontiers
Literature Overview
This article titled 'Addressing psychosocial vulnerability in rare diseases: a call to action from a European expert consensus study', published in Orphanet Journal of Rare Diseases, reviews psychosocial vulnerability issues faced by rare disease patients and identifies urgent psychosocial support needs and future research directions through Nominal Group Technique (NGT).
Background Knowledge
Rare diseases often cause significant psychological stress, social isolation, and financial burdens for patients and families due to high heterogeneity, low prevalence, and diagnostic delays. While existing studies reveal high rates of depression/anxiety in rare disease patients and psychosocial impacts on family members, systematic psychosocial support remains lacking. Based on Picker's patient-centered care framework combined with NGT methodology, this European-wide study integrates multidisciplinary expert opinions to identify eight core dimensions including emotional support, information access, and family involvement. It proposes strengthening international collaboration, inclusive research, and translational applications of common psychosocial models, filling critical gaps in rare disease psychosocial support frameworks for policy development and intervention design.
Research Methods and Experiments
The study employed Nominal Group Technique (NGT) during a two-day meeting in Nijmegen, Netherlands. After 2-hour NGT discussions among 17 participants (researchers, clinicians, therapists, and patient representatives), 62 psychosocial needs were generated and categorized into 57 core needs and 6 future research directions. Classification followed Picker's patient-centered care model across eight dimensions, validated through expert consensus.
Key Conclusions and Perspectives
Research Implications and Prospects
The study establishes a systematic framework for psychosocial support in rare diseases, facilitating the transition from disease-centered to patient-centered care. Cross-cultural and cross-regional research should be strengthened to improve global applicability of guidelines and interventions. Additionally, the urgency of developing mental health tools for rare diseases is highlighted, such as EURORDIS's ongoing mental health toolkit development.
Conclusion
This European expert consensus study systematically summarizes psychosocial support needs for rare disease patients and proposes six future research directions. Emotional support, healthcare accessibility, information transparency, and family involvement are confirmed as critical domains. The study underscores unique psychosocial vulnerability challenges compared to common diseases, advocating for higher policy prioritization. Current research gaps include limited patient representation, restricted regional coverage, and insufficient long-term funding. Future efforts should strengthen international collaboration, promote inclusive research designs, and adapt psychosocial intervention models from common chronic diseases to develop personalized support systems. With organizations like EURORDIS advancing mental health and well-being research, psychosocial support for rare diseases is expected to gain broader attention and resource allocation.